Christina Demuth

Increase in soluble PD-1 is associated with prolonged survival in patients with advanced EGFR -mutated non-small cell lung cancer treated with erlotinib

Steffen Filskov Sorensen, Christina Demuth, Britta Weber et al. · Lung Cancer · 2016 · 111 citations

Soluble Pd-1, Medicine, Immunology +11

MET amplification and epithelial-to-mesenchymal transition exist as parallel resistance mechanisms in erlotinib-resistant, EGFR-mutated, NSCLC HCC827 cells

Kristine Raaby Jakobsen, Christina Demuth, Anne Tranberg Madsen et al. · Oncogenesis · 2017 · 80 citations · Full text

Cell Proliferation, Nsclc Hcc827 Cells, Hcc827er Cells +19

Measuring KRAS Mutations in Circulating Tumor DNA by Droplet Digital PCR and Next-Generation Sequencing

Christina Demuth, Karen‐Lise Garm Spindler, Julia S. Johansen et al. · Translational Oncology · 2018 · 72 citations · Full text

Evaluation of VEGF A expression and microvascular density as prognostic factors in extrahepatic cholangiocarcinoma

Christian Möbius, Christina Demuth, Thomas Aigner et al. · European Journal of Surgical Oncology · 2007 · 70 citations

Tumor Biology, Surgical Oncology, Hepatology +15

Unraveling the potential clinical utility of circulating tumor DNA detection in colorectal cancer—evaluation in a nationwide Danish cohort

Tenna Vesterman Henriksen, Christina Demuth, Amanda Frydendahl et al. · Annals of Oncology · 2023 · 67 citations · Full text